ALK, ALK receptor tyrosine kinase, 238

N. diseases: 519; N. variants: 41
Source: ALL
Disease Type Disease Class Semantic Type N. genes d N. SNPs d Score gda EL gda EI gda N. PMIDs N. SNPs gda First Ref. Last Ref.
CUI: C0221505
Disease: Lesion of brain
Lesion of brain 		group Disease or Syndrome 188 9 0.010 None 1.000 1 2017 2017
CUI: C0278488
Disease: Carcinoma breast stage IV
Carcinoma breast stage IV 		disease Neoplastic Process 573 14 0.010 None 1.000 1 2016 2016
CUI: C0278506
Disease: Non-small cell lung cancer stage III
Non-small cell lung cancer stage III 		disease Neoplastic Process 16 1 0.010 None 1.000 1 2019 2019
CUI: C0279068
Disease: Childhood Solid Neoplasm
Childhood Solid Neoplasm 		phenotype Neoplastic Process 169 3 0.010 None 1.000 1 2016 2016
CUI: C0280099
Disease: Adult Solid Neoplasm
Adult Solid Neoplasm 		group Neoplastic Process 163 3 0.010 None 1.000 1 2016 2016
CUI: C0376705
Disease: Viral Load result
Viral Load result 		phenotype Finding 65 91 0.100 None 1.000 1 1 2019 2019
CUI: C0523465
Disease: Serum albumin measurement
Serum albumin measurement 		phenotype Laboratory Procedure 433 3282 0.100 None 1.000 1 1 2013 2013
CUI: C0855073
Disease: Undifferentiated (Embryonal) Sarcoma
Undifferentiated (Embryonal) Sarcoma 		disease Neoplastic Process 35 4 0.010 None 1.000 1 2014 2014
CUI: C0871470
Disease: Systolic Pressure
Systolic Pressure 		phenotype Clinical Attribute 843 1931 0.100 None 1.000 1 1 2016 2016
CUI: C1298180
Disease: Single tumor
Single tumor 		phenotype Neoplastic Process 63 4 0.010 None 1.000 1 2017 2017
CUI: C1333268
Disease: Deep Penetrating Nevus
Deep Penetrating Nevus 		disease Neoplastic Process 2 0.010 None 1.000 1 2018 2018
CUI: C1334363
Disease: Lung Large Cell Neuroendocrine Carcinoma
Lung Large Cell Neuroendocrine Carcinoma 		disease Neoplastic Process 11 0.010 None 1.000 1 2019 2019
CUI: C1336117
Disease: Stage IA Lung Adenocarcinoma AJCC v7
Stage IA Lung Adenocarcinoma AJCC v7 		disease Neoplastic Process 7 3 0.010 None 1.000 1 2018 2018
CUI: C1336554
Disease: T-Cell and NK-Cell Neoplasm
T-Cell and NK-Cell Neoplasm 		disease Neoplastic Process 7 0.010 None 1.000 1 2018 2018
CUI: C1337013
Disease: Differentiated Thyroid Gland Carcinoma
Differentiated Thyroid Gland Carcinoma 		disease Neoplastic Process 245 80 0.010 None 1.000 1 2015 2015
CUI: C1402294
Disease: Primary Lesion
Primary Lesion 		phenotype Disease or Syndrome 71 8 0.010 None < 0.001 1 2016 2016
CUI: C1510420
Disease: Cavitation
Cavitation 		disease Anatomical Abnormality 47 0.010 None 1.000 1 2019 2019
CUI: C1533022
Disease: Histiocytic proliferation
Histiocytic proliferation 		disease Disease or Syndrome 7 0.010 None 1.000 1 2019 2019
CUI: C1704376
Disease: Uterine Corpus Carcinosarcoma
Uterine Corpus Carcinosarcoma 		disease Neoplastic Process 33 0.010 None 1.000 1 2017 2017
CUI: C1708751
Disease: Low grade myofibroblastic sarcoma
Low grade myofibroblastic sarcoma 		disease Neoplastic Process 7 0.010 None 1.000 1 2008 2008
CUI: C1836230
Disease: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 		disease Finding 149 527 0.100 None 1.000 1 1 2019 2019
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
HIV-1, RESISTANCE TO 		phenotype Finding 147 526 0.100 None 1.000 1 1 2019 2019
CUI: C1836232
Disease: ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO 		phenotype Finding 147 526 0.100 None 1.000 1 1 2019 2019
CUI: C1836233
Disease: AIDS, PROGRESSION TO
AIDS, PROGRESSION TO 		phenotype Finding 147 526 0.100 None 1.000 1 1 2019 2019
CUI: C1869024
Disease: Severe cutaneous adverse reactions (SMQ)
Severe cutaneous adverse reactions (SMQ) 		phenotype Classification 2 2 0.100 None 1.000 1 1 2019 2019